SAMe 200 mg S-Adenosyl-Methionine
Product analysis
SAMe 200 mg S-Adenosyl-Methionine supplies a compound used in normal metabolism, though that role does not establish routine toxin clearance. The specific form is not disclosed, making comparisons with other preparations harder.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The specific SAMe form is not disclosed. That leaves its quality uncertain and limits close comparisons.
Ingredient Transparency63
The amount of SAMe is clear. Its specific form is missing, leaving the preparation less precisely described.
Value For Money40
SAMe offers limited value for the amount provided. The unspecified preparation gives no clear basis for a quality advantage at that cost.
Customer Satisfaction87
Customer feedback is very positive. Thousands of ratings provide a broad view of satisfaction, without establishing liver-related benefits.
Product Focus72
Liver-related support is the main intended use. SAMe’s role in normal metabolism does not establish routine toxin clearance from this serving.
- Format
Tablet - Container
- 30 Tablet(s)
- Per serving
- $0.67
- Customer rating
- 4.8 · 2,252 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
S-Adenosyl-Methionine | 200 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability17
Stabilized Salt Form
Packaging Integrity
Dose, Safety & Label Transparency60
Active Dosage Strength
Net SAMe Yield Transparency
Value40
Price Per 400mg Active Dose
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.
- Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.
- S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
- Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection.
- S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.